BNP Paribas Financial Markets
MENS

BNP Paribas Financial Markets’s Jyong Biotech MENS Stock Holding History

BNP Paribas Financial Markets’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.04K Buy
1,881
+581
+45% +$1.42K ﹤0.01% 5343
2025
Q4 		$5.13K Sell
1,300
-398
-23% -$14.1K ﹤0.01% 5259
2025
Q3 		$66.9K Buy
+1,698
New +$61.1K ﹤0.01% 4470

Other funds holding MENS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BNP Paribas Financial Markets's MENS Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Jyong Biotech (MENS) stake by 45% in Q1 2026, buying an estimated $1.42K and bringing the position to 1,881 shares worth $4.04K. The position accounts for ﹤0.01% of the portfolio, ranked #5343.

BNP Paribas Financial Markets first reported a position in MENS in Q3 2025 and has held it in 3 quarters since. The position peaked at $66.9K in Q3 2025. 17 funds tracked by Wall St. Rank hold MENS as of Q1 2026.

  • BNP Paribas Financial Markets held 1,881 shares of Jyong Biotech worth $4.04K as of Q1 2026.
  • BNP Paribas Financial Markets bought 581 Jyong Biotech shares in Q1 2026, an estimated $1.42K.
  • Jyong Biotech made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5343 holding.
  • BNP Paribas Financial Markets first reported a position in Jyong Biotech in Q3 2025 and has held it in 3 quarters since.
  • BNP Paribas Financial Markets's Jyong Biotech position peaked at $66.9K in Q3 2025.
  • 17 funds tracked by Wall St. Rank held Jyong Biotech as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.